Remdesivir Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 1 pharmaceutical company such as GILEAD SCIENCES INC. It is marketed under 1 brand name, including VEKLURY. Available in 2 different strengths, such as 100MG/VIAL, 100MG/20ML (5MG/ML), and administered through 2 routes including POWDER;INTRAVENOUS, SOLUTION;INTRAVENOUS.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 1 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"68188","ingredient":"REMDESIVIR","trade_name":"VEKLURY","family_id":"54bb390c1aa942649b8c","publication_number":"USRE46762E1","cleaned_patent_number":"RE46762","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-10-22","publication_date":"2018-03-27","legal_status":"Patented case"} USRE46762E1 27 Mar, 2018 Patented case 22 Oct, 2029
{"application_id":"68318","ingredient":"REMDESIVIR","trade_name":"VEKLURY","family_id":"54bb390c1aa942649b8c","publication_number":"US8318682B2","cleaned_patent_number":"8318682","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-10-22","publication_date":"2012-11-27","legal_status":"Granted"} US8318682B2 27 Nov, 2012 Granted 22 Oct, 2029
{"application_id":"68244","ingredient":"REMDESIVIR","trade_name":"VEKLURY","family_id":"54bb390c1aa942649b8c","publication_number":"US8008264B2","cleaned_patent_number":"8008264","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-03-06","publication_date":"2011-08-30","legal_status":"Patented case"} US8008264B2 30 Aug, 2011 Patented case 06 Mar, 2030
{"application_id":"68198","ingredient":"REMDESIVIR","trade_name":"VEKLURY","family_id":"1a70ffbfbecd4d1a9f13","publication_number":"US10065958B2","cleaned_patent_number":"10065958","drug_product_flag":"-","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-16","publication_date":"2018-09-04","legal_status":"Granted"} US10065958B2 04 Sep, 2018 Granted 16 Mar, 2032
{"application_id":"68241","ingredient":"REMDESIVIR","trade_name":"VEKLURY","family_id":"5097ed9ee4f147b7bcc3","publication_number":"US11492353B2","cleaned_patent_number":"11492353","drug_product_flag":"-","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-06-08","publication_date":"2022-11-08","legal_status":"Granted"} US11492353B2 08 Nov, 2022 Granted 08 Jun, 2032
{"application_id":"68174","ingredient":"REMDESIVIR","trade_name":"VEKLURY","family_id":"f1f3d712f0d949219f5d","publication_number":"US9949994B2","cleaned_patent_number":"9949994","drug_product_flag":"-","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-29","publication_date":"2018-04-24","legal_status":"Granted"} US9949994B2 24 Apr, 2018 Granted 29 Apr, 2036
{"application_id":"68074","ingredient":"REMDESIVIR","trade_name":"VEKLURY","family_id":"f1f3d712f0d949219f5d","publication_number":"US9724360B2","cleaned_patent_number":"9724360","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-29","publication_date":"2017-08-08","legal_status":"Granted"} US9724360B2 08 Aug, 2017 Granted 29 Apr, 2036
{"application_id":"68070","ingredient":"REMDESIVIR","trade_name":"VEKLURY","family_id":"928e6f153e774071ace2","publication_number":"US11382926B2","cleaned_patent_number":"11382926","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-03-16","publication_date":"2022-07-12","legal_status":"Granted"} US11382926B2 12 Jul, 2022 Granted 16 Mar, 2037
{"application_id":"68069","ingredient":"REMDESIVIR","trade_name":"VEKLURY","family_id":"928e6f153e774071ace2","publication_number":"US11007208B2","cleaned_patent_number":"11007208","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-03-16","publication_date":"2021-05-18","legal_status":"Granted"} US11007208B2 18 May, 2021 Granted 16 Mar, 2037
{"application_id":"68031","ingredient":"REMDESIVIR","trade_name":"VEKLURY","family_id":"928e6f153e774071ace2","publication_number":"US10695361B2","cleaned_patent_number":"10695361","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-03-16","publication_date":"2020-06-30","legal_status":"Granted"} US10695361B2 30 Jun, 2020 Granted 16 Mar, 2037
{"application_id":"68189","ingredient":"REMDESIVIR","trade_name":"VEKLURY","family_id":"9df8cafe5b9f4b59a625","publication_number":"US10675296B2","cleaned_patent_number":"10675296","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-01-10","publication_date":"2020-06-09","legal_status":"Patented Case"} US10675296B2 09 Jun, 2020 Patented Case 10 Jan, 2039
{"application_id":"123457","ingredient":"REMDESIVIR","trade_name":"VEKLURY","family_id":"da74855a259f41589526","publication_number":"US11975017B2","cleaned_patent_number":"11975017","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-01-10","publication_date":"2024-05-07","legal_status":"Patented case"} US11975017B2 07 May, 2024 Patented case 10 Jan, 2039
{"application_id":"68195","ingredient":"REMDESIVIR","trade_name":"VEKLURY","family_id":"9df8cafe5b9f4b59a625","publication_number":"US11266681B2","cleaned_patent_number":"11266681","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-01-10","publication_date":"2022-03-08","legal_status":"Patented case"} US11266681B2 08 Mar, 2022 Patented case 10 Jan, 2039
{"application_id":"122898","ingredient":"REMDESIVIR","trade_name":"VEKLURY","family_id":"","publication_number":"US11903953B2","cleaned_patent_number":"11903953","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2041-11-28","publication_date":"2024-02-20","legal_status":"Patented Case"} US11903953B2 20 Feb, 2024 Patented Case 28 Nov, 2041
{"application_id":"109369","ingredient":"REMDESIVIR","trade_name":"VEKLURY","family_id":"a9857e1c6fcf4065a40a","publication_number":"US11491169B2","cleaned_patent_number":"11491169","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2041-11-28","publication_date":"2022-11-08","legal_status":"Granted"} US11491169B2 08 Nov, 2022 Granted 28 Nov, 2041
{"application_id":"109371","ingredient":"REMDESIVIR","trade_name":"VEKLURY","family_id":"a9857e1c6fcf4065a40a","publication_number":"US11975012B2","cleaned_patent_number":"11975012","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2041-11-28","publication_date":"2024-05-07","legal_status":"Patented case"} US11975012B2 07 May, 2024 Patented case 28 Nov, 2041

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Remdesivir

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.